CA 19-9 Tumor Marker - Stanford Health Care

Skip to main content Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience. Menu Search Menu Search Home Close Doctors & Providers Clinics & Locations Conditions & Treatments Clinical Trials MyHealth Login Patients & Visitors Billing Insurance Help Paying Your Bill Medical Records Contact Us Video Visits Get a Second Opinion COVID-19 Resource Center Healthcare Professionals Referring Physicians Nursing Allied Healthcare About Us Quality & Safety Facilities Services & Planning Sustainability Careers Newsroom Make a Donation Stanford Health Care – Now

• Doctors & Providers, Clinics & Locations, Conditions & Treatments
• Patients & Visitors
• MyHealth

• Billing
• Insurance
• Medical Records
• Support Groups
• Help Paying Your Bill
• COVID-19 Resource Center

• Locations and Parking
• Visitor Policy
• Hospital Check-in
• Video Visits
• International Patients
• Contact Us

View All Information for Patients & Visitors We are available to assist you 24/7. 650-498-3333 GuestServices@stanfordhealthcare.org

View the changes to our visitor policy

 

View information for Guest Services

New to MyHealth?

Manage Your Care From Anywhere.

Access your health information from any device with MyHealth.  You can message your clinic, view lab results, schedule an appointment, and pay your bill.

ALREADY HAVE AN ACCESS CODE?

Activate Account

DON'T HAVE AN ACCESS CODE?

Create a New Account

NEED MORE DETAILS?

Learn More about MyHealth Learn More about Video Visits

MyHealth for Mobile

Get the iPhone MyHealth app Get the Android MyHealth app

WELCOME BACK

Forgot Username or Password? Need Help? Clear CA 19-9 Tumor Marker

• About

• About

Overview Types

• Prostate-specific antigen (PSA)
• Prostatic acid phosphatase (PAP)
• CA 125
• Carcinoembryonic antigen (CEA)
• Alpha-fetoprotein (AFP)
• Human chorionic gonadotropin (HCG)
• CA 19-9
• CA 15-3
• CA 27-29
• Lactate dehydrogenase (LDH)
• Neuron-specific enolase (NSE)
• Bladder tumor marker studies

Overview Types

• Prostate-specific antigen (PSA)
• Prostatic acid phosphatase (PAP)
• CA 125
• Carcinoembryonic antigen (CEA)
• Alpha-fetoprotein (AFP)
• Human chorionic gonadotropin (HCG)
• CA 19-9
• CA 15-3
• CA 27-29
• Lactate dehydrogenase (LDH)
• Neuron-specific enolase (NSE)
• Bladder tumor marker studies

CA 19-9

The CA 19-9 marker is associated with cancers in the colon, stomach, and bile duct. Elevated levels of CA 19-9 may indicate advanced cancer in the pancreas, but it is also associated with noncancerous conditions, including gallstones, pancreatitis, cirrhosis of the liver, and cholecystitis.

Previous Section Next Section Close Close Open Share on Facebook X (Twitter) Email